← Back to Search

Not Applicable

Pediatric Medication Management for Complex Medical Regimens (pMTM Trial)

N/A
Recruiting
Led By James A Feinstein, MD, MPH
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

pMTM Trial Summary

This trial aims to see if a new intervention helps children with medical issues and taking multiple medications.

Who is the study for?
This trial is for children aged 2-18 with complex chronic conditions who take 5 or more medications and receive care at Children's Hospital Colorado. It's not open to non-English speakers.Check my eligibility
What is being tested?
The study tests Pediatric Medication Therapy Management (pMTM) to see if it helps spot and handle medication-related issues in kids with multiple health problems taking many meds.See study design
What are the potential side effects?
Since this trial focuses on managing medication therapy rather than a new drug, side effects are related to potential adjustments in current medication regimens.

pMTM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medication-Related Problem (MRP) Count
Secondary outcome measures
Acute Healthcare Visit Count
Change in Parent-Reported Outcomes of Symptoms (PRO-Sx) Global Symptom Score

pMTM Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will receive the pMTM study intervention before a routine clinical visit.
Group II: Usual CareActive Control1 Intervention
The usual care group will receive standard-of-care medication management practices delivered during the course of a routine clinical visit.

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,821,977 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,155 Total Patients Enrolled
James A Feinstein, MD, MPHPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

Pediatric Medication Therapy Management (pMTM) (Not Applicable) Clinical Trial Eligibility Overview. Trial Name: NCT05761847 — N/A
Medication Adherence Research Study Groups: Usual Care, Intervention
Medication Adherence Clinical Trial 2023: Pediatric Medication Therapy Management (pMTM) Highlights & Side Effects. Trial Name: NCT05761847 — N/A
Pediatric Medication Therapy Management (pMTM) (Not Applicable) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05761847 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be qualified to join this investigation?

"In order to be eligible for this study, children aged between 2 and 18 years old must apply. The trial is seeking a total of 371 young candidates."

Answered by AI

Does this trial accept persons under the age of 70?

"For this specific study, participants must be between the ages of 2 and 18. In total, there are 50 clinical trials aimed at minors and 13 for those aged 65 or over."

Answered by AI

Are there opportunities available for individuals to take part in this research endeavor?

"Clinicaltrials.gov does not list this trial as currently recruiting patients, having been last updated on February 27th 2023 since its inception on April 1st the same year. Nevertheless, there are presently 57 other trials that require participants at this time."

Answered by AI
~247 spots leftby Sep 2027